BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE)
CUSIP: 07782B104
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Ordinary Shares, par value US$0.0001 per share
- Shares outstanding
- 37,379,062
- Total 13F shares
- 78,139
- Share change
- -74,809
- Total reported value
- $4,508,619
- Price per share
- $57.70
- Number of holders
- 18
- Value change
- -$5,101,966
- Number of buys
- 11
- Number of sells
- 11
Quarterly Holders Quick Answers
What is CUSIP 07782B104?
CUSIP 07782B104 identifies BLTE - BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 07782B104:
Top shareholders of BLTE - BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Lin Bioscience International Ltd. |
13D/G
|
— |
54%
|
17,095,263
|
$1,065,034,885 | $0 | 31 Dec 2024 | |
| Yu-Hsin Lin |
13D/G
|
— |
7.1%
|
2,287,070
|
$142,484,461 | $0 | 31 Dec 2024 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.22%
|
83,623
|
$5,537,515 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.05%
|
20,098
|
$1,330,890 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
12,753
|
$844,503 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.02%
|
8,162
|
$540,488 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.02%
|
5,689
|
$376,726 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
5,224
|
$345,933 | — | 31 Mar 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.01%
|
4,117
|
$272,000 | — | 31 Mar 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.01%
|
3,075
|
$203,626 | — | 31 Mar 2025 | |
| Virtus Investment Advisers, LLC |
13F
|
Company |
0.01%
|
2,589
|
$171,444 | — | 31 Mar 2025 | |
| GAMMA Investing LLC |
13F
|
Company |
0%
|
1,849
|
$122,441 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
1,435
|
$95,025 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0%
|
551
|
$36,487 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
316
|
$20,925 | — | 31 Mar 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
104
|
$6,887 | — | 31 Mar 2025 | |
| Caitong International Asset Management Co., Ltd |
13F
|
Company |
0%
|
49
|
$3,245 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
14
|
$927 | — | 31 Mar 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
6
|
$397 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
3
|
$199 | — | 31 Mar 2025 |
Institutional Holders of BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE) as of Q2 2025
As of 30 Jun 2025,
BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
78,139 shares.
The largest 10 holders included
STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, MARSHALL WACE, LLP, CITADEL ADVISORS LLC, JPMORGAN CHASE & CO, RENAISSANCE TECHNOLOGIES LLC, BNP PARIBAS FINANCIAL MARKETS, Cubist Systematic Strategies, LLC, EverSource Wealth Advisors, LLC, and UBS Group AG.
This page lists
18
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
18
Q2 2025 holders
18
Holder diff
0
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.